Farmácia/Notícias da Indústria

Diretrizes para tratamento de emergências médicas associadas com medicamentos psicotrópicos.

25 Mai, 2022 | 13:36h

Clinical Practice Guidelines for Management of Medical Emergencies Associated with Psychotropic Medications – Indian Journal of Psychiatry

---

Análise de especialista | Toxicidades vasculares de novas terapias oncológicas.

25 Mai, 2022 | 13:26h

Vascular Toxicities of Novel Cancer Therapies – American College of Cardiology

---

Estudo randomizado | Segurança e imunogenicidade da imunização com reforço heterólogo usando Ad5-nCoV em aerossol oral após 2 doses prévias de vacina com SARS-CoV-2 inativado em adultos na China.

24 Mai, 2022 | 11:52h

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial – The Lancet Respiratory Medicine

 

Comentário no Twitter

Mix-and-match typically refers to different shots. Here's a randomized trial of shots and an oral vaccine that ameliorates the immune responsehttps://t.co/FFWHEwS37Y @LancetRespirMed pic.twitter.com/JZyvrxCalS

— Eric Topol (@EricTopol) May 21, 2022

 

---

Medicamentos para agitação em pessoas com demência: benefícios e riscos.

24 Mai, 2022 | 11:36h

Drugs for agitation in people with dementia: benefits and risks – Evidently Cochrane

Estudo original: Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia – Cochrane Library

 

Comentário no Twitter (fio – clique para saber mais)

New blog for #DementiaActionWeek: https://t.co/UT1sdwNZRv @CharSquires & @jamie_garr look at the @CochraneDCIG evidence on drugs used to treat agitation & psychosis in people with #dementia & reflect on what doctors & families may want to consider when making treatment decisions pic.twitter.com/Ei7njr3ynL

— Cochrane UK (@CochraneUK) May 20, 2022

 

---

OMS valida a 11ª vacina contra COVID-19.

23 Mai, 2022 | 13:37h

WHO validates 11th vaccine for COVID-19 – World Health Organization

 

Comentário no Twitter

WHO issued an emergency use listing for CONVIDECIA, a vaccine manufactured by CanSino Biologics, China, adding to a growing portfolio of #COVID19 vaccines validated by WHO https://t.co/QdpHiasT2p pic.twitter.com/2B54FwiNDl

— World Health Organization (WHO) (@WHO) May 19, 2022

 

---

M-A | Duração do curso de antibióticos para pneumonia adquirida na comunidade em pacientes pediátricos ambulatoriais em países de alta renda – Tratamento com duração de 3-5 dias é tão efetivo e seguro quanto 7-10 dias.

23 Mai, 2022 | 13:33h

Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries – a systematic review and meta-analysis – Clinical Infectious Diseases

Conteúdos relacionados:

Antibiotics for Pediatric Pneumonia: Might Less Be Enough? – Annals of Emergency Medicine

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial – JAMA

Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial – The Pediatric Infectious Disease Journal

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial – JAMA Pediatrics

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians – Annals of Internal Medicine

Short-Course Antimicrobial Therapy for Pediatric Community-Acquired Pneumonia: The SAFER Randomized Clinical Trial – JAMA Pediatrics

Efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults: A systematic review and meta-analysis – Antimicrobial Agents and Chemotherapy

 

Comentário no Twitter

Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries – a systematic review and meta-analysis https://t.co/HxKywgCiXS
A short AB treatment of 3–5 days was equally effective and safe compared to the longer – 7–10 days

— Alexander V. Veselov 😷 (@veselov78) May 17, 2022

 

---

Covid-19 | OMS afirma que o segundo reforço de vacina pode ser benéfico em grupos de alto risco, mas tem um impacto “mínimo” para outros grupos.

23 Mai, 2022 | 13:31h

Covid-19: Second boosters may benefit at-risk groups but have “minimal” impact for others, says WHO – The BMJ

Diretriz original: Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 – World Health Organization

Recomendações relacionadas:

COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines –
European Centre for Disease Prevention and Control

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals – U.S. Food & Drug Administration

---

Opinião | Paxlovid ajuda as pessoas vacinadas contra Covid-19? Mostrem-nos os dados!

20 Mai, 2022 | 14:10h

Does Paxlovid help people who have been vaccinated against Covid-19? Show us the data! – STAT

---

Descoberta revela que bloquear a inflamação pode levar à dor crônica.

20 Mai, 2022 | 14:09h

Comunicado de imprensa: Discovery reveals blocking inflammation may lead to chronic pain – McGill University

Estudo original: Acute inflammatory response via neutrophil activation protects against the development of chronic pain – Science Translational Medicine

 

Comentário no Twitter

Challenging medical dogma:
A very important new report suggests that non-steroidal inflammatory medications for acute pain can lead to chronic painhttps://t.co/Z8yjFFBCkK @ScienceTM https://t.co/YGjkXbvNTa pic.twitter.com/f4xVezAhau

— Eric Topol (@EricTopol) May 18, 2022

 

---

Revisão de escopo | Diferentes tipos de ensaios clínicos aplicados à medicina personalizada.

20 Mai, 2022 | 13:35h

Study designs for clinical trials applied to personalised medicine: a scoping review – BMJ Open

---